Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation

Blood (2018) 131 (22): 2490–2499.

https://doi.org/10.1182/blood-2017-11-817973

Published: 2018

Includes: Supplemental data

Journal Articles

Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant

Blood (2017) 130 (13): 1585–1596.

https://doi.org/10.1182/blood-2017-05-784637

Published: 2017

Includes: Supplemental data

Journal Articles

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

Blood (2017) 130 (9): 1156–1164.

https://doi.org/10.1182/blood-2017-03-772368

Published: 2017

Includes: Supplemental data

Journal Articles

Exome Array Analyses Identify Low-Frequency Germline Variants Associated with Increased Risk of AML in a HLA-Matched Unrelated Donor Blood and Marrow Transplant Population

Alyssa I. Clay, PhD, Theresa Hahn, PhD, Qianqian Zhu, PhD, Li Yan, PhD, Leah Preus, MS, Daniel O. Stram, PhD, Christopher A. Haiman, ScD, Loreall C. Pooler, MS, Xin Sheng, MS, Kenan Onel, MD PhD, Qian Liu, MA, Qiang Hu, PhD, Song Liu, PhD, Xiaochun Zhu, MS, Stephen R. Spellman, MBS, Marcelo C. Pasquini, MD, Philip L. McCarthy, MD, Lara E. Sucheston-Campbell, PhD

Blood (2016) 128 (22): 42.

https://doi.org/10.1182/blood.V128.22.42.42

Published: 2016

Journal Articles

Replication of Candidate SNP Survival Analyses and Gene-Based Tests of Association with Survival Outcomes after an Unrelated Donor Blood or Marrow Transplant: Results from the Discovery-BMT Study

Ezgi Karaesmen#, MS, Abbas Rizvi#, MS, Qianqian Zhu, PhD, Li Yan, PhD, Qian Liu, MA, Qiang Hu, PhD, Leah Preus, MS, Alyssa I. Clay, PhD, Song Liu, PhD, Daniel O. Stram, PhD, Loreall C. Pooler, MS, Xin Sheng, MS, Christopher A. Haiman, ScD, Xiaochun Zhu, MS, Stephen R. Spellman, MBS, Marcelo C. Pasquini, MD, Philip L. McCarthy, MD, Theresa Hahn, PhD, Lara E. Sucheston-Campbell, PhD

Blood (2016) 128 (22): 71.

https://doi.org/10.1182/blood.V128.22.71.71

Published: 2016

Journal Articles

Exome Array Analyses Identify New Genes Influencing Survival Outcomes after HLA-Matched Unrelated Donor Blood and Marrow Transplantation

Qianqian Zhu#, PhD, Li Yan#, PhD, Qian Liu, MA, Qiang Hu, PhD, Leah Preus, MS, Alyssa I. Clay, PhD, Kenan Onel, MD PhD, Daniel O. Stram, PhD, Loreall C. Pooler, MS, Xin Sheng, MS, Christopher A. Haiman, ScD, Xiaochun Zhu, MS, Stephen R. Spellman, MBS, Marcelo C. Pasquini, MD, Philip L. McCarthy, MD, Song Liu, PhD, Theresa Hahn, PhD, Lara E. Sucheston-Campbell, PhD

Blood (2016) 128 (22): 518.

https://doi.org/10.1182/blood.V128.22.518.518

Published: 2016

Journal Articles

Replication of associations between genetic polymorphisms and chronic graft-versus-host disease

Blood (2016) 128 (20): 2450–2456.

https://doi.org/10.1182/blood-2016-07-728063

Published: 2016

Includes: Supplemental data

Journal Articles

Evidence for Heterogeneous Genetic Associations with Acute Lymphoblastic Leukemia (ALL) By Cytogenetics and Sex in High-Risk Patients Treated with Matched Unrelated Donor Allogeneic Blood or Marrow Transplant (URD-BMT)

Blood (2015) 126 (23): 2621.

https://doi.org/10.1182/blood.V126.23.2621.2621

Published: 2015

Journal Articles

Combined Donor and Recipient Non-HLA Genotypes Show Evidence of Genome Wide Association with Transplant Related Mortality (TRM) after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (URD-BMT) (DISCOVeRY-BMT study)

Blood (2015) 126 (23): 61.

https://doi.org/10.1182/blood.V126.23.61.61

Published: 2015

Journal Articles

Genome-Wide Association Study of Overall and Progression-Free Survival after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (DISCOVeRY-BMT study)

Blood (2015) 126 (23): 397.

https://doi.org/10.1182/blood.V126.23.397.397

Published: 2015

Journal Articles

Pre-Transplant C-Reactive Protein (CRP), Ferritin and Albumin As Biomarkers to Predict Transplant Related Mortality (TRM) after Allogeneic Hematopoietic Cell Transplant (HCT)

Andrew S. Artz, MD MS, Brent R. Logan, PhD, Xiaochun Zhu, MS, Görgün Akpek, MD MHS, Rodrigo Martino, MD PhD, Vikas Gupta, MD FRCP, FRCPath, Hillard M. Lazarus, MD, Mark R. Litzow, MD, Alison Wakoff Loren, MD MS, Navneet S. Majhail, MD MS, Richard T. Maziarz, MD, Philip L. McCarthy, MD, Uday R. Popat, MD, Wael Saber, MD MS, Stephen R. Spellman, MBS, Olle Ringdén, MDPhD, Kenneth R. Cooke, MD, Marcelo C. Pasquini, MD MS

Blood (2014) 124 (21): 422.

https://doi.org/10.1182/blood.V124.21.422.422

Published: 2014

Journal Articles

The Prognostic Value of YKL-40 in Allogeneic Hematopoietic Cell Transplantation

Brian Kornblit, MD PhD, Tao Wang, PhD, Stephanie J. Lee, MD MPH, Stephen R. Spellman, MBS, Xiaochun Zhu, MS, Katharina Fleischhauer, MD, Carlheinz Müller, MD PhD, Michael R. Verneris, MD, Julia S. Johansen, MD DMSci, Lars Vindelov, MD DMSci, Peter Garred, MD DMSci

Blood (2014) 124 (21): 1176.

https://doi.org/10.1182/blood.V124.21.1176.1176

Published: 2014

Journal Articles

Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation

Richard Aplenc, Mei-Jie Zhang, Lillian Sung, Xiaochun Zhu, Vincent T. Ho, Kenneth Cooke, Christopher Dvorak, Gregory Hale, Luis M. Isola, Hillard M. Lazarus, Philip L. McCarthy, Richard Olsson, Michael Pulsipher, Marcelo C. Pasquini, Nancy Bunin

Blood (2014) 123 (22): 3504–3511.

https://doi.org/10.1182/blood-2013-03-490334

Published: 2014

Includes: Supplemental data

Journal Articles

Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation

Christopher Bredeson, Jennifer LeRademacher, Kazunobu Kato, John F. DiPersio, Edward Agura, Steven M. Devine, Frederick R. Appelbaum, Marcie R. Tomblyn, Ginna G. Laport, Xiaochun Zhu, Philip L. McCarthy, Vincent T. Ho, Kenneth R. Cooke, Elizabeth Armstrong, Angela Smith, J. Douglas Rizzo, Jeanne M. Burkart, Marcelo C. Pasquini

Blood (2013) 122 (24): 3871–3878.

https://doi.org/10.1182/blood-2013-08-519009

Published: 2013

Includes: Supplemental data

Journal Articles

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI

Blood (2013) 122 (24): 3863–3870.

https://doi.org/10.1182/blood-2013-07-514448

Published: 2013

Journal Articles

Lower Transplant-Related Mortality and Improved Survival for Patients with AML in First CR Receiving BuCy Compared to Cy/TBI As Myeloablative Preparation for Allogeneic Transplantation: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Edward A. Copelan, MD, Betty K. Hamilton, MD, Kwang W Ahn, PhD, Xiaochun Zhu, MS, Belinda Avalos, MD, Brian J. Bolwell, MD, Robert Peter Gale, MD, PhD, DSc, Jorge E. Cortes, MD, Matt Kalaycio, MD, Richard T. Maziarz, MD, Wael Saber, MD, MS

Blood (2012) 120 (21): 217.

https://doi.org/10.1182/blood.V120.21.217.217

Published: 2012

Journal Articles

Comorbidity Index (CI) in Autologous Hematopoietic Cell Transplantation (HCT) for Malignant Diseases: Validation of the HCT-CI

Marcelo C. Pasquini, MD, MS, Brent R. Logan, PhD, Vincent T Ho, MD, Philip L. McCarthy, Jr., MD, Kenneth R. Cooke, MD, J. Douglas Rizzo, MD, Xiaochun Zhu, MS, Mohamed L. Sorror, MD, MSc

Blood (2012) 120 (21): 814.

https://doi.org/10.1182/blood.V120.21.814.814

Published: 2012

Journal Articles

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes At US Transplant Centers: A Center for International Blood and Marrow Transplant Research (CIBMTR) Study

Mohamed L. Sorror, MD, MSc, Brent R. Logan, PhD, Xiaochun Zhu, MS, J. Douglas Rizzo, MD, Kenneth R. Cooke, MD, Philip L. McCarthy, Jr., MD, Vincent T Ho, MD, Barry Storer, PhD, Marcelo C Pasquini, MD, MS

Blood (2012) 120 (21): 733.

https://doi.org/10.1182/blood.V120.21.733.733

Published: 2012

Journal Articles

The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Can Prospectively Discriminate Risks Affecting Overall Survival in Pediatric and Adult Patients with Non-Malignant Diseases

Monica S Thakar, MD, Brent R. Logan, PhD, Marcelo C. Pasquini, MD, MS, Philip L. McCarthy, Jr., MD, Vincent T Ho, MD, Kenneth R. Cooke, MD, Xiaochun Zhu, MS, J. Douglas Rizzo, MD, Mohamed L. Sorror, MD, MSc

Blood (2012) 120 (21): 737.

https://doi.org/10.1182/blood.V120.21.737.737

Published: 2012

Journal Articles

Lille Scoring System Rather Than DIPSS Is a Better Predictive of Overall Mortality After Allogeneic Hematopoietic Cell Transplantation (HCT) for Primary Myelofibrosis Using Reduced Intensity Conditioning: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Vikas Gupta, MD, FRCP, FRCPath, Kwang W Ahn, PhD, Xiaochun Zhu, MS, Zhenhuan Hu, MPH, Parameswaran Hari, MBBS, MD, MRCP, Richard T. Maziarz, MD, Jorge E. Cortes, MD, Matt Kalaycio, MD, Wael Saber, MD, MS

Blood (2012) 120 (21): 432.

https://doi.org/10.1182/blood.V120.21.432.432

Published: 2012

NARROW

Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation

Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

Exome Array Analyses Identify Low-Frequency Germline Variants Associated with Increased Risk of AML in a HLA-Matched Unrelated Donor Blood and Marrow Transplant Population

Replication of Candidate SNP Survival Analyses and Gene-Based Tests of Association with Survival Outcomes after an Unrelated Donor Blood or Marrow Transplant: Results from the Discovery-BMT Study

Exome Array Analyses Identify New Genes Influencing Survival Outcomes after HLA-Matched Unrelated Donor Blood and Marrow Transplantation

Replication of associations between genetic polymorphisms and chronic graft-versus-host disease

Evidence for Heterogeneous Genetic Associations with Acute Lymphoblastic Leukemia (ALL) By Cytogenetics and Sex in High-Risk Patients Treated with Matched Unrelated Donor Allogeneic Blood or Marrow Transplant (URD-BMT)

Combined Donor and Recipient Non-HLA Genotypes Show Evidence of Genome Wide Association with Transplant Related Mortality (TRM) after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (URD-BMT) (DISCOVeRY-BMT study)

Genome-Wide Association Study of Overall and Progression-Free Survival after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (DISCOVeRY-BMT study)

Pre-Transplant C-Reactive Protein (CRP), Ferritin and Albumin As Biomarkers to Predict Transplant Related Mortality (TRM) after Allogeneic Hematopoietic Cell Transplant (HCT)

The Prognostic Value of YKL-40 in Allogeneic Hematopoietic Cell Transplantation

Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation

Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI

Lower Transplant-Related Mortality and Improved Survival for Patients with AML in First CR Receiving BuCy Compared to Cy/TBI As Myeloablative Preparation for Allogeneic Transplantation: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Comorbidity Index (CI) in Autologous Hematopoietic Cell Transplantation (HCT) for Malignant Diseases: Validation of the HCT-CI

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes At US Transplant Centers: A Center for International Blood and Marrow Transplant Research (CIBMTR) Study

The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Can Prospectively Discriminate Risks Affecting Overall Survival in Pediatric and Adult Patients with Non-Malignant Diseases

Lille Scoring System Rather Than DIPSS Is a Better Predictive of Overall Mortality After Allogeneic Hematopoietic Cell Transplantation (HCT) for Primary Myelofibrosis Using Reduced Intensity Conditioning: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only